Performance analysis of Coherus Biosciences (CHRS)
Annual Return
Over the past 3 years, CHRS has had an average annual return of -30.90%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, CHRS has had an average annual return of -35.91%, underperforming the benchmark SPY, which returned +12.78% annual.
Over the past 10 years, CHRS has had an average annual return of -24.62%, underperforming the benchmark SPY, which returned +14.91% annual.
Since Nov 6, 2014, CHRS has had an average annual return of -17.01%, underperforming the benchmark SPY, which returned +13.60% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0% | +2.93% | -58.58% | -57.95% | -50.38% | -8.17% | -3.47% | +98.94% | +2.84% | -68.74% | +22.61% | +40.69% |
| 2014 | |||||||||||
| +29.42% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +52.13% | -22.71% | +1.21% | +5.07% | -10.44% | -11.97% | +1.44% | -0% | |||||
| 2025 | -14.44% | -5.98% | -27.27% | +27.66% | -24.36% | -6.15% | +28.62% | +23.32% | +41.41% | +2.38% | -18.99% | +4.36% | +2.93% |
| 2024 | -35.44% | +6.04% | +4.81% | -17.99% | -7.14% | -4.92% | -11.01% | -9.75% | -25.14% | -28.36% | +63.62% | +13.13% | -58.58% |
| 2023 | +7.07% | -20.16% | +1.02% | +5.72% | -43.44% | +4.41% | +12.88% | +10.60% | -29.83% | -10.42% | -36.43% | +56.36% | -57.95% |
| 2022 | -22.56% | -4.61% | +9.50% | -29.98% | -18.80% | -1.37% | +17% | +31.99% | -14.04% | -9.47% | -21.15% | +15.46% | -50.38% |
| 2021 | +8.17% | -13.62% | -10.04% | +1.30% | -11.08% | +5.09% | -5.64% | +22.45% | +0.57% | +4.10% | +11% | -14.05% | -8.17% |
| 2020 | +0.20% | +7.26% | -16.17% | +2.34% | +12.29% | -4.19% | -1.51% | +7.85% | -3.32% | -9.10% | +10.73% | -5.85% | -3.47% |
| 2019 | +48.73% | +6.54% | -4.88% | +16.71% | +18.72% | +16.93% | -23.89% | +31.92% | -8.69% | -14.27% | +3.56% | +0.08% | +98.94% |
| 2018 | +14.77% | -1.99% | +11.62% | +9.51% | +28.92% | -10.26% | +36.07% | +5.77% | -18.11% | -29.16% | -5.38% | -18.17% | +2.84% |
| 2017 | -0.89% | -15.41% | -10.38% | -9.22% | +2.86% | -27.34% | -8.71% | +10.30% | -7.61% | -15.74% | -20.43% | -1.68% | -68.74% |
Drawdown analysis of Coherus Biosciences (CHRS)
The maximum drawdown for the CHRS was -98.21%, occurring on Nov 4, 2024. This drawdown has not yet recovered.
The current CHRS drawdown is -96.21%.
Since Nov 6, 2014 CHRS has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.21% | Jul 22, 2015 | 2338 | Nov 4, 2024 | Ongoing | Ongoing | Ongoing |
| -35.86% | Mar 2, 2015 | 48 | May 8, 2015 | 43 | Jul 10, 2015 | 91 |
| -17.86% | Feb 9, 2015 | 5 | Feb 17, 2015 | 7 | Feb 26, 2015 | 12 |
| -16.39% | Nov 10, 2014 | 28 | Dec 19, 2014 | 4 | Dec 26, 2014 | 32 |
| -11.46% | Jan 14, 2015 | 6 | Jan 23, 2015 | 4 | Jan 29, 2015 | 10 |
| -5.87% | Jan 29, 2015 | 4 | Feb 4, 2015 | 1 | Feb 5, 2015 | 5 |
| -3.87% | Jan 9, 2015 | 1 | Jan 12, 2015 | 1 | Jan 13, 2015 | 2 |
| -3.39% | Feb 26, 2015 | 1 | Feb 27, 2015 | 1 | Mar 2, 2015 | 2 |
| -3.30% | Dec 29, 2014 | 3 | Jan 2, 2015 | 2 | Jan 6, 2015 | 5 |
| -0.90% | Jul 16, 2015 | 1 | Jul 17, 2015 | 1 | Jul 20, 2015 | 2 |
| -0.27% | Jul 20, 2015 | 1 | Jul 21, 2015 | 1 | Jul 22, 2015 | 2 |